Suchergebnisse - "Nawrocki, Steffan T."

1

Mechanisms of mTOR inhibitor resistance in cancer therapy

von: Carew, Jennifer S.

2011, in: Targeted oncology

Wird geladen...
2

Moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies

von: Jones, Trace M.

2019, in: Chinese journal of cancer

Wird geladen...
3

Mammalian target of rapamycin as a target in hematological malignancies

von: Kelly, Kevin R.

2011, in: Targeted oncology

Wird geladen...
4

The combination of intravenous Reolysin and gemcitabine induces reovirus replication and endoplasmic reticular stress in a patient with KRAS-activated pancreatic cancer

von: Mahalingam, Devalingam

2015, in: BMC cancer

Wird geladen...
5

Inhibiting signal transducer and activator of transcription-3 increases response to gemcitabine and delays progression of pancreatic cancer

von: Venkatasubbarao, Kolaparthi

2013, in: Molecular cancer

Wird geladen...
6

Blocking “don't eat me” signal of CD47-SIRPα in hematological malignancies, an in-depth review

von: Russ, Atlantis

2018, in: Blood reviews

Wird geladen...
7

Src activation of Stat3 is an independent requirement from NF-κB activation for constitutive IL-8 expression in human pancreatic adenocarcinoma cells

von: Trevino, Jose G.

2006, in: Angiogenesis

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!